Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "AMR"

139 News Found

Dr. Andreas Amrein joins Advanced Clinical to lead expansion in APAC, Europe and Canada
People | March 09, 2022

Dr. Andreas Amrein joins Advanced Clinical to lead expansion in APAC, Europe and Canada

With over 20 years of international leadership experience, Dr. Amrein has led many teams and organizations across over 30 geographies


Amrita University launches wearable device for home monitoring of glucose and BP
Digitisation | March 02, 2022

Amrita University launches wearable device for home monitoring of glucose and BP

Patients can use the wearable, non-invasive device to measure six body parameters including blood glucose, blood pressure, heart rate, blood oxygen, respiratory rate and 6-lead ECG, from the comfort of their home


Venus Remedies join AMR alliance to combat global health threat
Biotech | February 07, 2022

Venus Remedies join AMR alliance to combat global health threat

The antimicrobial resistance alliance recently released its third Progress Report, reflecting on collective achievements from the life sciences industry


Amrutanjan Health Care opens first store in Chennai
News | December 02, 2021

Amrutanjan Health Care opens first store in Chennai

The offline store launch will complement the E-commerce website in building a rich consumer shopping experience


Caspian Debt to fund healthcare companies, partners Samridh
Startup | August 20, 2021

Caspian Debt to fund healthcare companies, partners Samridh

Caspian Debt has in principle committed up to Rs 35 crores to SAMRIDH’s commercial debt investment pool


Amring Pharmaceuticals launch Isoproterenol Hydrochloride Injection USP
News | August 10, 2021

Amring Pharmaceuticals launch Isoproterenol Hydrochloride Injection USP

The drug is indicated for mild and transient episodes of heart block


Samrat Pharmachem reports Q4 FY21 PAT at Rs. 1.55 Cr
News | July 02, 2021

Samrat Pharmachem reports Q4 FY21 PAT at Rs. 1.55 Cr

The company has posted net profit / (loss) of Rs.5.33 crores for the 12 months period ended March 31, 2021


Nxera secures exclusive APAC rights to DMD drug Vamorolone in deal with Santhera
News | January 11, 2026

Nxera secures exclusive APAC rights to DMD drug Vamorolone in deal with Santhera

Nxera will take full responsibility for regulatory approvals, clinical development where required, manufacturing and commercialization in the licensed territories


Reimagining India’s Pharmaceutical Sector: From Global Supplier to Innovation Leader
Opinion | January 07, 2026

Reimagining India’s Pharmaceutical Sector: From Global Supplier to Innovation Leader

India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry


Bengaluru healthtech firm Biomoneta secures USFDA nod for air purifier
Healthcare | December 08, 2025

Bengaluru healthtech firm Biomoneta secures USFDA nod for air purifier

Captured microbes are then neutralized on engineered microbicidal surfaces